• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

24
results for

"Lung"

Filter

Article category

Keywords

Publication year

Authors

"Lung"

Reviews

[English]
Current and emerging treatment strategies for Mycobacterium avium complex pulmonary disease: a narrative review
Chiwook Chung
Received February 23, 2025  Accepted March 14, 2025  Published online March 26, 2025  
DOI: https://doi.org/10.12771/emj.2025.00080    [Epub ahead of print]
The Mycobacterium avium complex (MAC), comprising M. avium and M. intracellulare, constitutes the predominant cause of nontuberculous mycobacterial pulmonary disease (NTM-PD) in Korea, followed by the M. abscessus complex. Its global prevalence is increasing, as shown by a marked rise in Korea from 11.4 to 56.7 per 100,000 individuals between 2010 and 2021, surpassing the incidence of tuberculosis. Among the older adult population (aged ≥65 years), the prevalence escalated from 41.9 to 163.1 per 100,000, accounting for 47.6% of cases by 2021. Treatment should be individualized based on prognostic indicators, including cavitary disease, low body mass index, and positive sputum smears for acid-fast bacilli. Current therapeutic guidelines recommend a 3-drug regimen—consisting of a macrolide, rifampin, and ethambutol—administered for a minimum of 12 months following culture conversion. Nevertheless, treatment success rates are only roughly 60%, and over 30% of patients experience recurrence. This is often attributable to reinfection rather than relapse. Antimicrobial susceptibility testing for clarithromycin and amikacin is essential, as resistance significantly worsens prognosis. Ethambutol plays a crucial role in preventing the development of macrolide resistance, whereas the inclusion of rifampin remains a subject of ongoing debate. Emerging therapeutic strategies suggest daily dosing for milder cases, increased azithromycin dosing, and the substitution of rifampin with clofazimine in severe presentations. Surgical resection achieves a notable sputum conversion rate of approximately 93% in eligible candidates. For refractory MAC-PD, adjunctive therapy with amikacin is advised, coupled with strategies to reduce environmental exposure. Despite advancements in therapeutic approaches, patient outcomes remain suboptimal, highlighting the urgent need for novel interventions.
  • 316 View
  • 19 Download
[English]
Impact of pulmonary tuberculosis on lung cancer screening: a narrative review
Jeong Uk Lim
Received February 16, 2025  Accepted March 17, 2025  Published online March 26, 2025  
DOI: https://doi.org/10.12771/emj.2025.00052    [Epub ahead of print]
Lung cancer remains a leading cause of cancer-related mortality worldwide. Low-dose computed tomography (LDCT) screening has demonstrated efficacy in reducing lung cancer mortality by enabling early detection. In several countries, including Korea, LDCT-based screening for high-risk populations has been incorporated into national healthcare policies. However, in regions with a high tuberculosis (TB) burden, the effectiveness of LDCT screening for lung cancer may be influenced by TB-related pulmonary changes. Studies indicate that the screen-positive rate in TB-endemic areas differs from that in low-TB prevalence regions. A critical challenge is the differentiation between lung cancer lesions and TB-related abnormalities, which can contribute to false-positive findings and increase the likelihood of unnecessary invasive procedures. Additionally, structural lung damage from prior TB infections can alter LDCT interpretation, potentially reducing diagnostic accuracy. Nontuberculous mycobacterial infections further complicate this issue, as their radiologic features frequently overlap with those of TB and lung cancer, necessitating additional microbiologic confirmation. Future research incorporating artificial intelligence and biomarkers may enhance diagnostic precision and facilitate a more personalized approach to lung cancer screening in TB-endemic settings.
  • 184 View
  • 17 Download

Case Reports

[English]
Stress-induced Cardiomyopathy Associated with Non-Small Cell Lung Cancer Presenting as Hyponatremia
Jong Taek Kim, Seok Ho Seo, Seung Hyun Lee, Dae Won Park, Dong Goo Kang, Seung Uk Lee
Ewha Med J 2015;38(2):90-93.   Published online July 29, 2015
DOI: https://doi.org/10.12771/emj.2015.38.2.90

Stress-induced cardiomyopathy, so-called Takotsubo cardiomyopathy, has recently been reported in Japan. Stress-induced cardiomyopathy is characterized by transient left ventricular apical dysfunction and ballooning, with normal coronary angiographic findings. We describe a rare case of stress-induced cardiomyopathy associated with lung adenocarcinoma presenting as hyponatremia.

Citations

Citations to this article as recorded by  
  • Hyponatremia and takotsubo syndrome: a review of pathogenetic and clinical implications
    Kenan Yalta, Orkide Palabıyık, Muhammet Gurdogan, Ertan Yetkın
    Heart Failure Reviews.2023; 29(1): 27.     CrossRef
  • 91 View
  • 0 Download
  • 1 Crossref
[English]
Metastatic Pulmonary Mucoepidermoid Carcinoma with Fulminant Clinical Course
Yong Won Park, Seon Bin Yoon, Mi Ju Cheon, Young Min Koh, Hyeon Sik Oh, Se Joong Kim, Seung Hyeun Lee
Ewha Med J 2015;38(2):85-89.   Published online July 29, 2015
DOI: https://doi.org/10.12771/emj.2015.38.2.85

Pulmonary mucoepidermoid carcinoma (MEC) is a rare form of lung cancer that originates from submucosal glands of tracheobronchial tree. Unlike low-grade tumor with benign nature, high-grade case is even rarer and has aggressive clinical features with no definite treatment option. Here, we report a case of high-grade pulmonary MEC with fulminant clinical course. A 74-year-old man presented with cough, sputum and mental change. Chest imaging showed massive mediastinal lymphadenopathy with obstructive pneumonia, and multiple metastases in lung and adrenal gland. Bronchoscopy showed polypoid masses obstructing right main bronchus and bronchus intermedius. Histopathology revealed a mixture of glandular structure lined with mucussecreting cells and nests of squamoid cells with nuclear atypia and pleomorphism, which is compatible with high-grade MEC. We intensively treated the patient with combination antibiotics and ventilator care. However, the patient did not respond to the treatment and rapidly deteriorated, and finally expired a month after diagnosis.

  • 70 View
  • 0 Download

Original Articles

[English]

No abstract available in English.

  • 44 View
  • 0 Download
[English]
Objective

Experiments were designed to investigate whether there is any correlation between concentration of plasma nitric oxide and pathological severity of acute rejection after lung allograft.

Methods

After single lung allograft, dogs were immunosuppressed with triple standard therapy and divided into 2 groups. Group 1(Immunosuppression ; n=4) was maintained on immunosuppression as controls. In group 2(Rejection ; n=15), triple therapy was discontinued to induce acute rejection from postoperative day 5. Plasma concentration of nitric oxide was measured by chemiluminescence method prior to surgery and at postoperative day 9. At postoperative day 9, dogs were sacrificed and rejection was graded pathologically by a working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group.

Plasma nitric oxide level of day 9 was compared to that of prior to surgery in each group. Correlation between plasma nitric oxide level and pathological grade of acute rejection at day 9 in group 2(Rejection) was examined.

Results

In group 2(Rejection), plasma nitric oxide level fo day 9 was elevated significantly, compared to that of prior to surgery(12.28±2.10 vs 6.46 0.57µM/L ; p<0.05).But plasma nitric oxide level of day 9 didn't significantly correlate with the pathological grades of rejection in group 2(Spearman's coefficient r=-0.2094 ; p>0.05).

Conclusion

Plasma concentration of nitric oxide was elevated during acute rejection, but didn't correlate with the pathological severity of rejection.

  • 52 View
  • 0 Download
[English]
Endothelin-l Content of Bronchoalveolar Lavage in Allografted Lungs during Acute Rejection
Young-Sik Park
Ihwa Ŭidae chi 1996;19(4):493-497.   Published online July 24, 2015
DOI: https://doi.org/10.12771/emj.1996.19.4.493
Objective

The aim of this study was to investigate whether or not endothelin-1 content of bronchoalveolar lavage was elevated in allografted lungs during acute rejection.

Methods

After single lung allotransplantation, dogs were immunosuppressed with triple standard therapy and divided into 2 groups. Group 1(Immunosupression ; n=4) was maintained on immunosuppression as controls. In group 2(Rejectin ; n=13), triple therapy was discontinued to induce acute rejection from postoperative day 5.

At postoperative day 9, broncholaveolar lavage was done through bronchoscopy in native unoperated lung and transplanted lung in group 1. Bronchoalveolar lavage was repeated in group 2 in the same way. Endothelin-1 content of bronchoalveolar lavage was measured by radiommunoassay.

Endothelin-1 content in transplanted lung of group 2 was compared to that of transplanted lung of group 1 and to that of native unoperated lung of group 2.

Results

Endothelin-1 content of bronchoalveolar lavage in transplanted lung of group 2 was comparable to that of group 1(42.18±26.39 vs 3.08±3.08pg/ml ; p=0.08). Endothelin-1 content of bronchoalveolar lavage in transplanted lung of group 2 was comparable to that of native unoperated lung of group 2(42.18±26.39 vs 3.74±2.62pg/ml ; p=0.07).

Conclusion

Endothelin-1 content of bronchoalveolar lavage in transplanted lung was altered during acute rejection, but without statistical significance.

  • 51 View
  • 0 Download
[English]
Objective

Experiment was designed to compare cellular profile of bronchoalveolar lavage following induced bacterial infection, acute rejection and acute rejection plus bacterial infection after lung allotranplantation.

Methods

After single lung allotransplantation, dogs were immunosuppressed with standard triple therapy and divided into 4 groups. Group I(n=4) was maintained on immunosuppression as controls. In group II(n= 6), infection was induced by bronchoscopic inoculation of E. coli at postoperative day 5. In group III(n=6), triple therapy was discontinued to induce acute rejection from postoperative day 5. In group IV(n= 8), triple therapy was discontinued and bacterial infection was induced by bronchoscopic inoculation of E coli at postoperative day 5.

At postoperative day 9, bronchoalveolar lavage was obtained in the native and transplanted lung resprctively through bronchoscopy. Total cell count and differential cell count of bronchoalveolar lavage were compared in four groups.

Results

In the native lung, there was no significant difffrence in total cell count and differential cell count in four groups. In the transplanted lung, total cell count of group II(Infection) was increased, compared to group III(Rejection) (p <0.05). In the transplanted lung, differential neutrophil count of group II(Infection) and group III(Rejection) were increased, compared to group I(Immunosuppression) (p <0.05). In the transplanted lung, differential macrophage count of group II(Infection), III(Rejection) and IV(Rejecion plus Infection) were decreased, compared to group I(Immunosuppuression) (p<0.05).

Conclusion

Cellular profile of bronchoalveolar lavage reflected the pathological process ofinfection or acute rejection following lung allotransplantation in the transplanted lung. But conventional total and differential cell counts had limitation to differentiate either process.

  • 40 View
  • 0 Download
[English]
Change of Plasma Nitric Oxide during Acute Rejection or Infection after Lung Allotransplantation
Young-Sik Park
Ihwa Ŭidae chi 1996;19(3):331-335.   Published online July 24, 2015
DOI: https://doi.org/10.12771/emj.1996.19.3.331
Objective

This study was aimed to investigate whether there is any change in palsma nitric oxide during acute rejection of infection after lung allotransplantation.

Methods

After lung allotransplantation, dogs were immunosuppressed with standardized triple therapy and divided into 3 groups : in group 1(control: n=4), immunosuppression was maintained; in group 2(n=7), triple therapy discontinued to induce acute rejection at the postoperative day 5; in group 3(n=6), infection was inudced by bronchoscopic inoculation of E. coli at the postoperative day 5. Plasma nitric oxide was measured by chemiluminescene method prior to surgery(day 0), and at postoperative day 5 and 9. In each group, plasma nitric oxide level at day 9 was compared to that at day 0. Plasma nitric oxide levels at day 9 were compared in three groups.

Results

During acute rejection period, plasma nitric oxide concentration was found to be elevated significantly at postoperative day 9, compared to day 0(11.52±2.58 vs 6.01±0.88uM/L ; p<0.05). However, plasma nitric oxide concentration wasn't altered by the E. coli-induced infection(14.53±5.19 vs 6.12±0.98uM/L ; p>0.05). Plasma nitric oxide of day 9 weren't different in three groups(p>0.05).

Conclusion

Plasma nitric oxide may be a good marker for acute rejection after allotrans-plantation, but not for infection.

  • 45 View
  • 0 Download

Case Reports

[English]
Wedge Resection of Lung Metastasis after Chemotherapy in Patients with Testicular Choriocarcinoma
Jee Young Oh, Soon Nam Lee, Young Yo Park, Kwang Ho Kim, Woon Sup Han
Ihwa Ŭidae chi 1995;18(3):269-275.   Published online July 24, 2015
DOI: https://doi.org/10.12771/emj.1995.18.3.269

Choriocarcinonla is very rare malignancy, accounting for less than 1% of all testicular germcell tumor. However, it is an important disease in the field of oncology, as it represents ahighly curable malignancy. and one in which the incidence is focused on young patients attheir peak of productivity. In nonserninomatous germ cell testis tumor, assessment of prognosticfactors is related to develop a basis for more rational therapy for each individual patient.Along with prognostic staging, appropriate treatment shoud be applied to each patient to improve disease-free survival. And. surgical resection of residual masses after cisplatin-based chemotherapy is an established adjuvant to chemotherapy, because complete remission can be improvedabout 10% with appropriately timed complete resection of residual diseases. So, we reporta case of a 27-year old male patient with testicular choriocarcinoma who presented with multiplelung metastases after radical orchiectomy. He recieved lung wedge resection after 8 cycles ofcisplatin, etoposide, ifosfamide combination chemotherapy. and complete remission was confirmed and maintained.

  • 66 View
  • 0 Download
[English]
A Case of Surgical Resection of Pulmonary Metastases in Patient with Resected Primary Colom Carcinoma
Jee Young Oh, Seung Ki Ryu, Seung Jung Kim, Jun-Hyuk Choi, Soon Nam Lee, Kwang Ho Kim, Woo Sup Han
Ihwa Ŭidae chi 1995;18(2):137-141.   Published online July 24, 2015
DOI: https://doi.org/10.12771/emj.1995.18.2.137

Although the role of surgical management of metastatic disease from primary carcinoma of the coln and recutm is still controversial, resection of hepatic metastasis improves survival rate of patients with primary colorectal carcinoma treated locally. The lung is the most common site of extra-abdominal metastasis following resection of a prymary colorectal tumor and not amenable to curative therapy.

It is possible to resect the pulmonary metastasis in selected patients following resection of colorectal cancers, but the 5-year survival rates are ranged from 9% to 57%. Authors report a case of resection of pulmonary metastasis occured 3 years after resection of primary colon carcinoma.

  • 51 View
  • 0 Download
[English]
A Case of Pulmonary Tuberculosis Presenting as Diffuse Interstitial Lung Disease Associated with the Lymphadenopathy of Mediastinum and Abdomen
Eun Young Lee, Young Sun Hong, Seon Hee Cheon, Young Sik Park, Seung Yeon Baek, Woon Sup Han
Ihwa Ŭidae chi 1993;16(4):395-399.   Published online July 24, 2015
DOI: https://doi.org/10.12771/emj.1993.16.4.395

The diffuse interstitial lung diseases are a heterogeneous group of diffuse inflammatory disorders of the lower respiratory tract characterized by derangements of the alveolar walls and loss of functional alveolar capillary units. The most common causes of diffuse interstitial lung diseases are idiopathic pulmonary fibrosis, sarcoidosis, collagen vascular disorders, hypersensitivity pneumonitis and pneumoconiosis. Especially, the miliary tuberculosis is also leading cause in Korea, but pulmonary tuberculosis presenting as diffuse interstitial lung disease except miliary tubercuaosis is rare. We report a case of pulmonary tuberculosis presenting as diffuse interstitial lung disease associated with the tyrnphadenopathy of mediastinum and abdomen.

  • 51 View
  • 0 Download
[English]
Ovarian Metastasis from Non-Small Cell Lung Cancer Responding to Erlotinib
Ik Ju Jung, Seung Taek Lim, Yeon Seok Choi, Tae Soo Jang, Sun Hee Oh, Joo Ah Lee, Do Yeun Cho
Ewha Med J 2015;38(1):46-49.   Published online March 26, 2015
DOI: https://doi.org/10.12771/emj.2015.38.1.46

Ovarian cancer is generally primary cancer and less frequently originates from metastasis from non-gynecological cancer. Ovarian metastasis from lung cancer represents only 2~4% of all ovarian metastatic cancers. We report a case of ovarian metastasis of non-small cell lung cancer with epidermal growth factor receptor mutation. The patient underwent cytoreductive surgery for the ovarian mass and erlotinib therapy for the metastatic lung cancer. Erlotinib therapy markedly decreased the size of lung mass.

  • 55 View
  • 0 Download
[English]
Chemotherapy in Small Cell Lung Cancer with End-Stage Renal Disease on Hemodialysis
Sang Il Choi, Sun Seob Park, Eun Jeong Ko, Si Won Lee, Mihong Choi, Kiwon Kim
Ewha Med J 2014;37(Suppl):S5-S9.   Published online December 24, 2014
DOI: https://doi.org/10.12771/emj.2014.37.S.S5

Small cell lung cancer is primarily treated with chemotherapy. For patients with end-stage renal disease (ESRD), systemic chemotherapy is often challenging since renal excretion of chemotherapeutic agents might be decreased due to impaired renal function, leading to increased toxicity. No consensus is made so far regarding appropriate dosage and combination of chemotherapeutic agents for patients on hemodialysis. We report two cases of chemotherapy without significant toxicity in small cell lung cancer patients who were on hemodialysis for ESRD.

  • 63 View
  • 0 Download
[English]
Syndrome of Inappropriate Secretion of Antidiuretic Hormone after Lung Transplantation
Young Su Joo, Chang-Yun Yoon, Seung Gyu Han, Eunyoung Lee, In Mee Han, Moon Sung Woo, Se Hee Park, Tae-Hyun Yoo
Ewha Med J 2014;37(Suppl):S41-S43.   Published online December 24, 2014
DOI: https://doi.org/10.12771/emj.2014.37.S.S41

A 54-year-old man was diagnosed as syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 7 days after lung transplantation, whereas the preoperative serum sodium level was normal. Hypertonic saline infusion with furosemide did not improve hyponatremia, however, tolvaptan corrected his serum sodium levels from 123 mEq/L to 131 mEq/L. Seven days after maintenance of tolvaptan, this drug was discontinued and hyponatremia did not occur. Herein, we report a case of SIADH after lung transplantation treated with tolvaptan.

  • 66 View
  • 0 Download
[English]
Anesthetic Management for Lung Adenocarcinoma Experienced Acute Neurocardiogenic Syncope and Cardiac Arrest
Jin Hye Han, Youn Jin Kim, Jong Hak Kim, Dong Yeon Kim, Guie Yong Lee, Chi Hyo Kim
Ewha Med J 2014;37(Suppl):S28-S32.   Published online December 24, 2014
DOI: https://doi.org/10.12771/emj.2014.37.S.S28

Vasovagal syncope is one of the most common causes of transient syncope during anesthesia for elective surgery in patients with a history of syncope and requires special attention and management of anesthetics. The causes and pathophysiological mechanism of this condition are poorly understood, but it has a benign clinical course and recovers spontaneously. However, in some cases, this condition may cause cardiovascular collapse resulting in major ischemic organ injury and be life threatening. Herein we report a case and review literature, regarding completing anesthesia safely during an elective surgery of a 59-year-old female patient with history of loss of consciousness due to suspected vasovagal syncope followed by cardiovascular collapse and cardiac arrest, which required cardiopulmonary resuscitation and insertion of a temporary pacemaker and intra-aortic balloon pump immediately after a fine-needle aspiration biopsy of a lung nodule located in the right middle lobe.

  • 46 View
  • 0 Download
[English]
A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement
Min Hwan Kim, Yehyun Park, Hye Jung Park, Ah-young Ji, Changho Song, Moo-Nyun Jin, Young Ju Kim, Sun Wook Kim, Jung-Hee Lee, In-Soo Kim, Hye Ryun Kim, Joohang Kim, Byoung Chul Cho
Ewha Med J 2014;37(1):46-51.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.46

The rearrangement of c-ros oncogene 1 (ROS1) has been recently identified as an important molecular target in non small cell lung cancer (NSCLC). ROS1 rearrangement and epidermal growth factor receptor (EGFR) mutation were mutually exclusive each other in previous studies, and the clinical implication of co-existence of the two genetic alterations has not been determined. We report a case of 46-year-old female never-smoker NSCLC patient whose tumor harbored ROS1 rearrangement and EGFR mutation concomitantly. She had undergone curative surgery for stage IIIA NSCLC, and the recurrence in left pleura and brain occurred at 2 years after the surgery. She received several lines of chemotherapy including docetaxel plus carboplatin, erlotinib, pemetrexed, and gemcitabine. Erlotinib therapy showed a favorable treatment response with progression-free survival of 9.5 months and partial response of tumor on radiologic evaluations. This case represents a successful erlotinib treatment in a NSCLC patient with concurrent ROS1 rearrangement and EGFR mutation.

  • 72 View
  • 0 Download
[English]
Radiation Recall Dermatitis Induced by Gefitinib
Beodeul Kang, Ah Young Leem, Young Jae Kim, Eudong Hwang, Yujung Yun, Sun Wook Kim, Hyo Song Kim
Ewha Med J 2013;36(Suppl):S17-S21.   Published online December 23, 2013
DOI: https://doi.org/10.12771/emj.2013.36.S.S17

Radiation recall dermatitis refers to an acute inflammatory reaction in a previously irradiated field triggered by the administration of certain drugs days to years after the exposure to radiation. Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor and is an effective treatment for patients with advanced stage of non small cell lung cancer (NSCLC). Here, we report a rare case of gefitinib induced radiation recall dermatitis. A 52-year-old woman with a metastatic NSCLC had received a palliative radiation therapy of 20 cGy on spine metastasis area (C6-T6). After 24 days of receiving radiation therapy, she had started to take gefitinib. Eight months after taking drug, pain, swelling and erythema of skin were occurred on previously irradiated field. These symptoms were resolved after the cessation of gefitinib for 6 days and the topical use of steroid.

Citations

Citations to this article as recorded by  
  • Gefitinib

    Reactions Weekly.2014; 1490(1): 21.     CrossRef
  • 85 View
  • 0 Download
  • 1 Crossref
[English]
Amiodarone-Induced Pulmonary Toxicity: Percutaneous Needle Aspiration Biopsy and Ultrastructural Findings
In Sook Kang, Jin Hwa Lee, Sun Hee Sung, Seong Hoon Park
Ewha Med J 2013;36(2):144-148.   Published online September 26, 2013
DOI: https://doi.org/10.12771/emj.2013.36.2.144

Amiodarone has been widely used for supraventricular and ventricular arrhythmias and many patients benefit from its effectiveness in treating potentially life-threatening arrhythmias. However, this drug can cause multi-organ toxicity, including amiodarone-induced pulmonary toxicity (APT). Not only does amiodarone have a long half-life but also is lipophilic and therefore can easily accumulate in tissues. Hence, it is difficult to monitor therapeutic levels and side effects, making it difficult to predict toxicities. In this case, we describe multi-organ complications secondary to amiodarone use, especially APT combined with pneumonia with atypical pathogens and pulmonary hemorrhage. The patient reached a high cumulative dose of amiodarone despite a low maintenance dose of amiodarone. This case highlights an unusual presentation of APT with multi-organ toxicity and we review articles regarding the association between the cumulative dose of amiodarone and amiodarone-induced toxicities.

Citations

Citations to this article as recorded by  
  • Amiodarone

    Reactions Weekly.2014; 1492(1): 8.     CrossRef
  • 89 View
  • 0 Download
  • 1 Crossref

Original Articles

[English]
The Immunohistochemical and Electron Microscopic Observation of Metastatic Small Cell Lung Cancer of Liver
Sun Hee Roh, Kyu Won Chung, Jae Jung Park, Suh Eun Bae, Il Hwan Moon, Kwon Yoo, Min Sun Cho
Ihwa Ŭidae chi 2009;32(1):3-8.   Published online March 31, 2009
DOI: https://doi.org/10.12771/emj.2009.32.1.3

Small cell lung cancer accounts for about 20% of all lung cancers. At the time of diagnosis, the majority of patients already have metastasis. The liver is one of the most common sites of distant metastasis of lung cancer. Small cell lung cancer arises from neuroendocrine cells which produce hormone, hormone producing granules can be seen under electron microscope . A 65-year-old male was admitted to hospital because of jaundice and right upper quadrant pain. The chest roentgenogram and chest computed tomography(CT) scan showed a 3 cm mass in right upper lobe with bilateral mediastinal lymphadenopathy and right pleural effusion. The abdomen CT scan revealed multiple masses in the liver with heterogenous pattern suggesting metastatic orgin. Though the immunohistochemistry and electron miscroscopy, he was diagnosed as metastatic small cell lung cancer of liver. We report a case of the Immunohistochemical and Electron Microscopic Observation of Metastatic Small Cell Lung Cancer of Liver.

  • 68 View
  • 0 Download
[English]

No abstract available in English.

Citations

Citations to this article as recorded by  
  • Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses
    Daniel Steffens, Hilmy Ismail, Linda Denehy, Paula R. Beckenkamp, Michael Solomon, Cherry Koh, Jenna Bartyn, Neil Pillinger
    Annals of Surgical Oncology.2021; 28(12): 7120.     CrossRef
  • 97 View
  • 0 Download
  • 1 Crossref

Case Reports

[English]
A Case of Acute Eosinophilic Pneumonia Following Cigarette Smoking
Eun Hwa Choi, Hye Jung Chang, Min Jung Kang, Ji Young Oh, In Je Kim, Yun Su Sim, Jin Wook Moon, Jung Hyun Chang, Jin Hwa Lee, Sun Hee Sung
Ihwa Ŭidae chi 2006;29(2):127-132.   Published online September 30, 2006
DOI: https://doi.org/10.12771/emj.2006.29.2.127

Acute eosinophilic pneumonia is characterized by acute febrile disease with diffuse interstitial infiltration on chest radiography, eosinophilic infiltration of lung parenchyma on lung biopsy and good response at corticosteroid therapy. There has been several reports that support cigarette smoking recently, even though the pathogenesis is not clear. We encountered a case of acute eosinophilic pneumonia induced by cigarette smoking, who, being a 20-year-old man, presented with acute onset of fever after his first cigarette smoking. His clinical symptoms and the infiltrations on onset x-ray improved after a treatment with corticosteroid.

  • 51 View
  • 0 Download
[English]
A Case of Ectopic ACTH Syndrome Associated with Small Cell Lung Cancer
Hyun-Ju Song, Kum-Hei Ryu, Su-Hyun Kim, Su-Jin Yoon, Do-Yeun Kim, Seock-Ah Im, Chu-Myong Seong, Heasoo Koo, Soon-Nam Lee
Ihwa Ŭidae chi 2003;26(2):187-191.   Published online June 30, 2003
DOI: https://doi.org/10.12771/emj.2003.26.2.187

We report a case of extensive stage SCLC with EAS confirmed by immunohistochemical stain of ACTH in tumor cells who died early due to rapidly progressive acute respiratory distress and pneumonia before the start of chemotherapy and corticosteroid blocking agent. Through our case, we learn how important early diagnosis and treatment of EAS associated with SCLC are and hope to apply to other cases from now on.

  • 52 View
  • 0 Download
Original Article
[English]
CT Findings of Tuberculous Pneumonia in Diabetic Patients: Comparison with Tuberculosis in Nondiabetics
Yookyung Kim, Sung Won Park, Sang Min Lee, Kyung Soo Cho
Ihwa Ŭidae chi 2001;24(3):109-114.   Published online September 30, 2001
DOI: https://doi.org/10.12771/emj.2001.24.3.109
Objective

To evaluate the CT findings of pulmonary tuberculosis in diabetic patients compared with patients without underlying disease.

Methods

The chest CT scans of pulmonary tuberculosis in 23 diabetic patients(M : F=21 : 2 ; mean age, 59 yrs.) and in 24 nondiabetic patients(M : F=12 : 12 ; mean age, 48 yrs.) were retrospectively analyzed by two radiologists ; decisions were reached by consensus.

Results

The frequencies of consolidation(100%, 42%), inhomogeneity of consolidation(70%, 21%), multiple small low-density areas(52%, 13%), cavitation(70%, 25%), multiple small cavity(35%, 4%), bizarre-shaped cavity(22%, 0%), air-bronchogram(95%, 54%) were significantly more common in pulmonary tuberculosis in diabetic patients than in nondiabetic patients(p<.05). There was no significant difference in localization of pulmonary lesions between diabetic and nondiabetic patients.

Conclusion

Diabetic patients have a high prevalence of inhomogeneous consolidation containing multiple small low densities and multiple or bizarre-shaped cavities than do patients without diabetics.

  • 56 View
  • 0 Download
TOP